期刊文献+

健康教育路径在介入治疗不稳定型心绞痛患者中的应用效果探讨 被引量:3

Effects of health education path in the interventional treatment of patients with unstable angina pectoris
下载PDF
导出
摘要 目的探讨健康教育路径在介入治疗不稳定型心绞痛患者中的应用效果。方法选取符合介入治疗标准的患者60例,按入院先后顺序分为对照组和观察组各30例。对照组采用传统的方法实施健康教育,观察组采用健康教育路径模式实施健康教育,比较2组的应用效果。结果观察组对护理工作的满意度得分为(9.67±0.36)分高于对照组(9.01±0.39)分,疾病健康认知得分(94.51±2.29)高于对照组(76.50±2.46)。结论健康教育路径应用于介入治疗不稳定型心绞痛患者,能明显提高健康教育的效果和护理质量。
作者 王素珍
出处 《中国临床护理》 2014年第4期342-344,共3页 Chinese Clinical Nursing
  • 相关文献

参考文献4

二级参考文献34

  • 1李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:194
  • 2肖正安,杨艳芳,贾晓宇.临床路径在子宫肌瘤手术患者健康教育中的应用[J].国际护理学杂志,2006,25(8):660-661. 被引量:35
  • 3Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002, 40(7) :1366-1374.
  • 4Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J,2002,23 ( 23 ) : 1809 -1840.
  • 5Erhardt L, Herlitz J, Bossaert L, et al. Task force on the management of chest pain. Eur Heart J, 2002, 23 ( 15 ) : 1153-1176.
  • 6CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996, 348(9038) :1329-1339.
  • 7Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001 , 345 ( 7 ) :494-502.
  • 8Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, 2001, 358(9281):527-533.
  • 9Simoons ML, GUSTO IV-ACS Investigators. Effect of glycopmtein Ⅱb/Ⅲa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation:the GUSTO IV-ACS randomised trial. Lancet, 2001,357(9272) :1915-1924.
  • 10Platlat Receptor Inhibitor in Ischemic Syndrome Management(PRISM) study investigator. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management ( PRISM )Study Investigators. N Engl J Med, 1998, 338(21 ) :1498-1505.

共引文献2193

同被引文献30

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部